EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Boarding pyroptosis onto nanotechnology for cancer therapy

Weiyue Ban, Zhichao Chen, Tao Zhang, Tengda Du, Dianqiu Huo, Guorui Zhu, Zhonggui He, Jin Sun, Mengchi Sun

Journal of Controlled Release · 2024-06 · 370 · 653-676

DOI: 10.1016/j.jconrel.2024.05.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-06. Verfasst von Weiyue Ban und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Pyroptosis, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 150 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a non-apoptotic programmed cellular inflammatory death mechanism characterized by gasdermin (GSDM) family proteins, has gathered significant attention in the cancer treatment. However, the alarming clinical trial data indicates that pyroptosis-mediated cancer therapeutic efficiency is still unsatisfactory. It is essential to integrate the burgeoning biomedical findings and innovations with potent technology to hasten the development of pyroptosis-based antitumor drugs. Considering the rapid development of pyroptosis-driven cancer nanotherapeutics, here we aim to summarize the recent advances in this field at the intersection of pyroptosis and nanotechnology. First, the foundation of pyroptosis-based nanomedicines (NMs) is outlined to illustrate the reliability and effectiveness for the treatment of tumor. Next, the emerging nanotherapeutics designed to induce pyroptosis are overviewed. Moreover, the cross-talk between pyroptosis and other cell death modalities are discussed, aiming to explore the mechanistic level relationships to provide guidance strategies for the combination of different types of antitumor drugs. Last but not least, the opportunities and challenges of employing pyroptosis-based NMs in potential clinical cancer therapy are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNeoplasmsAntineoplastic AgentsHumansAnimalsNanomedicineNanotechnologyNanoparticles

Stichwörter der Autor:innen

Clinical cancer therapyPyroptosisPyroptosis-based nanomedicines (NMs)Pyroptosis-driven cancer nanotherapeuticsPyroptosis-mediated cancer therapeutic efficiency

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China. Electronic address:…
  • Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China. Electronic address: sunmengc…

Zitieren

APA

Ban, W., Chen, Z., Zhang, T., Du, T., Huo, D., Zhu, G., He, Z., Sun, J., & Sun, M. (2024). Boarding pyroptosis onto nanotechnology for cancer therapy. Journal of Controlled Release, 370, 653-676. https://doi.org/10.1016/j.jconrel.2024.05.014

Vancouver

Ban W, Chen Z, Zhang T, Du T, Huo D, Zhu G, et al. Boarding pyroptosis onto nanotechnology for cancer therapy. Journal of Controlled Release. 2024;370:653-676. doi:10.1016/j.jconrel.2024.05.014

BibTeX
@article{Ban2024,
  author = {Ban, Weiyue and Chen, Zhichao and Zhang, Tao and Du, Tengda and Huo, Dianqiu and Zhu, Guorui and He, Zhonggui and Sun, Jin and Sun, Mengchi},
  title = {Boarding pyroptosis onto nanotechnology for cancer therapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {370},
  pages = {653--676},
  doi = {10.1016/j.jconrel.2024.05.014}
}
Kostenlos starten →